Zions Bancorporation’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$3.2M Buy
40,996
+14,762
+56% +$1.19M 0.2% 98
2024
Q3
$2.11M Buy
26,234
+4,278
+19% +$346K 0.15% 129
2024
Q2
$1.82M Buy
21,956
+3,377
+18% +$297K 0.15% 117
2024
Q1
$1.59M Buy
18,579
+963
+5% +$75.6K 0.12% 150
2023
Q4
$1.51M Buy
17,616
+1,199
+7% +$104K 0.1% 152
2023
Q3
$1.47M Buy
16,417
+2,311
+16% +$206K 0.13% 131
2023
Q2
$1.2M Buy
14,106
+216
+2% +$18.3K 0.1% 160
2023
Q1
$1.15M Buy
13,890
+1,547
+13% +$125K 0.1% 165
2022
Q4
$971K Buy
12,343
+1,954
+19% +$157K 0.08% 169
2022
Q3
$769K Buy
10,389
+13
+0.1% +$933 0.08% 178
2022
Q2
$676K Buy
10,376
+2,165
+26% +$128K 0.07% 208
2022
Q1
$519K Buy
8,211
+2,377
+41% +$129K 0.05% 238
2021
Q4
$309K Buy
5,834
+1,031
+21% +$62.8K 0.03% 273
2021
Q3
$339K Buy
4,803
+705
+17% +$44.5K 0.03% 253
2021
Q2
$273K Buy
4,098
+1,681
+70% +$119K 0.03% 264
2021
Q1
$268K Sell
2,417
-11
-0.5% -$1.36K 0.03% 238
2020
Q4
$288K Buy
2,428
+111
+5% +$11.9K 0.04% 207
2020
Q3
$202K Buy
2,317
+1,294
+126% +$113K 0.03% 222
2020
Q2
$92K Buy
1,023
+104
+11% +$10.5K 0.01% 281
2020
Q1
$92K Buy
+919
New +$99.7K 0.02% 270

Other funds holding HAE

Zions Bancorporation's HAE Position: Q4 2024 in Review

Zions Bancorporation increased its Haemonetics (HAE) stake by 56% in Q4 2024, buying an estimated $1.19M and bringing the position to 40,996 shares worth $3.2M. The position accounts for 0.2% of the portfolio, ranked #98.

Zions Bancorporation first reported a position in HAE in Q1 2020 and has held it in 20 quarters since. 309 funds tracked by Wall St. Rank hold HAE as of Q4 2024.

  • Zions Bancorporation held 40,996 shares of Haemonetics worth $3.2M as of Q4 2024.
  • Zions Bancorporation bought 14,762 Haemonetics shares in Q4 2024, an estimated $1.19M.
  • Haemonetics made up 0.2% of Zions Bancorporation's portfolio in Q4 2024, its #98 holding.
  • Zions Bancorporation first reported a position in Haemonetics in Q1 2020 and has held it in 20 quarters since.
  • 309 funds tracked by Wall St. Rank held Haemonetics as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.